Association of body mass index (BMI) with overall survival (OS) in metastatic melanoma (MM) patients (pts) treated with combined anti-CTLA4 + anti-PD1. This is an ASCO Meeting Abstract from the 2018 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback